American Society of Clinical Oncology

SHERPA: White

People

  1. O'Reilly
    O'Reilly
  2. Yu
    Yu
  3. Varghese
    Varghese
  4. Kelsen
    Kelsen
  5. Li
    Li
  6. Zervoudakis
    Zervoudakis
  7. Park
    Park
  8. Chou
    Chou
  9. Goldberg
    Goldberg
  10. Ku
    Ku

Groups

  1. Center for Pancreatic Cancer Research (13)
  2. Department of Medicine (13)
  3. Gastrointestinal Oncology Service (13)
  4. Hematologic Malignancies, Division of (13)
  5. Solid Tumor Oncology Division (13)
  6. Center for Hematologic Malignancies (8)
  7. CTCR Scholars (5)
  8. MSK Grad Students (5)
  9. Master of Science in Clinical and Translational Cancer Research (5)
  10. Survivorship Research (5)
Search Within
  1. "Eileen O'Reilly"
  2. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (3)
Groups
  1. Center for Pancreatic Cancer Research (13)
  2. Department of Medicine (13)
  3. Gastrointestinal Oncology Service (13)
  4. Hematologic Malignancies, Division of (13)
  5. Solid Tumor Oncology Division (13)
  6. Center for Hematologic Malignancies (8)

More Groups

People
  1. Eileen O'Reilly (13)
  2. Kenneth Yu (8)
  3. Anna Varghese (6)
  4. Alice Zervoudakis (5)
  5. David Kelsen (5)
  6. Geoffrey Ku (5)

More People

Years
  1. 2023 (3)
  2. 2020 (2)
  3. 2019 (1)
  4. 2018 (2)
  5. 2017 (1)
  6. 2011 (1)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Journal of Oncology Practice (1)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer
    Meeting Abstract

    Tuli, R.; Keane, F.; Schoenfeld, J. D.; O'Connor, C.; White, C.; Chou, J. F.; Schwartz, C.; Larsen, M.; Brenner, R.; Park, W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The SHARON trial: A study of melphalan, BCNU, hydroxocobalamin, ascorbic acid, and autologous stem cell rescue for metastatic pancreatic cancer with an inherited BRCA mutation
    Meeting Abstract

    Yu, K. H.; Weekes, C. D.; Chen, Y. B. A.; Glazier, J. A.; Glazier, A.; Dahi, P.; Giralt, S.; O'Reilly, E. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced pancreatic adenocarcinoma (LA PDAC)
    Meeting Abstract

    Keane, F.; Schoenfeld, J. D.; Crowley, F.; O'Connor, C. A.; White, C.; Schwartz, C.; Brenner, R.; Larsen, M.; Park, W.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Actionable alterations (AA) in gastrointestinal (GI) cancers: Rate of detection and receipt of matched therapies (MT)
    Meeting Abstract

    Greally, M.; Tuvy, Y.; Millang, B. M.; O'Reilly, E. M.; Yaeger, R.; Saltz, L. B.; Ku, G. Y.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pancreatic ductal adenocarcinoma (PDAC), BRCA: Detailed analysis and outcomes of cohort from Memorial Sloan Kettering Cancer Center (MSK)
    Meeting Abstract

    Momtaz, P.; O'Connor, C. A.; Chou, J. F.; Capanu, M.; Yu, K. H.; Varghese, A. M.; Park, W.; Zervoudakis, A.; Li, J.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Homologous recombination deficiency (HRD): A biomarker for first-line (1L) platinum in advanced pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Park, W.; Wong, W.; Yu, K. H.; Varghese, A. M.; Riaz, N.; Balachandran, V. P.; El Dika, I. H.; Raj, N. P.; Khalil, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Pilot study of gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban for advanced pancreatic adenocarcinoma: An interim analysis
    Meeting Abstract

    Yu, K. H.; Mantha, S.; Tjan, C.; Kaufmann, E. S.; Brenner, R.; Lowery, M. A.; Ku, G. Y.; Raj, N. P.; Shcherba, M.; Goldberg, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Nano-liposomal irinotecan and 5-FU/LV (N+F) for the treatment of advanced PDAC: Memorial Sloan Kettering (MSK) single cancer center evaluation
    Meeting Abstract

    Glassman, D. C.; Desai, A. M.; Ku, G. Y.; Li, J.; Harding, J. J.; Varghese, A. M.; O'Reilly, E. M.; Yu, K. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Clinical characterization of pancreatic ductal adenocarcinomas (PDAC) with mismatch repair (MMR) gene mutations
    Meeting Abstract

    Hu, Z. I.; Varghese, A. M.; Shia, J.; Zervoudakis, A.; Lowery, M. A.; Yu, K. H.; Chalasani, S. B.; Robson, M. E.; Stadler, Z. K.; Caron, P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Electronic chemotherapy order entry: A major cancer center's implementation
    Journal Article

    Sklarin, N. T.; Granovsky, S.; O'Reilly, E. M.; Zelenetz, A. D.
    Journal of Oncology Practice (2011)

    Fulltext@MSK | Save